Strategies to Identify and
Evaluate Efficacy of Interventions Having the Greatest Impact on Providing
Public Health Protection: A Regulatory Perspective
Presentation
Slide 3
Where Does FDA Acquire Its
Data?
Data Acquisition
Slide 6
Data
Acquisition:
Survey Contracts
Data Quality Issues
Analysis and Interpretation
of Data
Approaches for Analysis and
Interpretation
Professional Advice and
Analysis
Listeria monocytogenes Risk
Assessments
FDA/FSIS Risk Assessment
Slide 14
Two-Dimensional Cluster
Analysis
Slide 16
What-If Scenario: Inhibiting
Growth in
Frankfurters-Not Reheated
FAO/WHO Risk Assessment
FAO/WHO Listeria
monocytogenes Risk Assessment
Predicted Relationships
Between Dose and Incidence
Role of Compliance
High Risk Subpopulations
Risk Assessment as a Tool
for Evaluating Interventions
Selecting Risk Management
Options
FDA Risk Management Themes
FDA/CDC Listeria
monocytogenes Action Plan
Efficient Risk
Management
Use science-based efficient risk management strategies to target highest L.
monocytogenes risk products and practices
Empowering Consumers: Improving Health through Better Information
Consumer messages and information to reduce exposure to L. monocytogenes,
particularly by vulnerable groups such as the elderly and pregnant women
Improving Consumer Safety
Reducing L. monocytogenes risk with improved food manufacturing and
distribution
2003 Update - Action Plan
Monitoring and Review of
Food Safety Program
Monitoring and Review
Why Monitoring and Review?
Why Monitoring and Review?
Examples of Triggers Leading
to Changes in Risk Management Approaches
Tools For Monitoring
Using Case Data to Determine
Effectiveness of a Food Safety Program
Concluding Remarks